Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Meta-Analysis of Phase II-III Randomized Trials on Adjuvant Immune Checkpoint Inhibitors in Solid Tumors

  • By

  • Mariam Grazia Polito

  • Luisana Sisca

  • Davide Caruso

  • Antonella Cosimati

  • Carla Adriana Ramirez Reinaga

  • Etien Leka

  • Daniele Santini

  • Gian Paolo Spinelli

  • September 7, 2026

Share

Original Source(s)

Adjuvant immune checkpoint inhibitors across solid tumors: a meta-analysis of phase II-III randomized trials

  • by Mariam Grazia Polito, Luisana Sisca, Davide Caruso, Antonella Cosimati, Carla Adriana Ramirez Reinaga, Etien Leka, Daniele Santini, Gian Paolo Spinelli

  • September 7, 2026

Related Content

Therapy-induced immunoediting and the evolution of cancer immune escape

The Circadian Skin: Chronobiology as a New Frontier in Dermatological Therapy

Occupation and oncology: cancer care in Palestine